Avaleht › Autoimmuunhaigused › Illinois
Autoimmuunhaigused kliinilised uuringud osariigis Illinois
14 uuringut haiguse Autoimmuunhaigused jaoks otsivad osalejaid osariigis Illinois.
Linnad osariigis Illinois
Ametlik uuringutekst (inglise keeles)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Willow Rheumatology Wellness, Willowbrook
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07621809A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- University of Chicago, Chicago
VärbamineFaas 2
Vanused 16–70 · Kõik sood · Uuendatud 17. sept 2026 · NCT07328581RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
VärbamineFaas 2/3
Vanused 6–75 · Kõik sood · Uuendatud 17. sept 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Chicago, Department of Medicine: Rheumatology, Chicago
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. sept 2026 · NCT07103746A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- The University of Chicago Medical Center, Chicago
VärbamineFaas 1
Vanused 18–74 · Kõik sood · Uuendatud 10. sept 2026 · NCT07085104RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
VärbamineFaas 1/2
Vanused 18–65 · Kõik sood · Uuendatud 26. aug 2026 · NCT06121297A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
VärbamineFaas 1/2
Vanused 35–70 · Kõik sood · Uuendatud 21. aug 2026 · NCT06575426RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
VärbamineFaas 2/3
Vanused 18–75 · Kõik sood · Uuendatud 17. aug 2026 · NCT06328777RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
VärbamineFaas 1/2
Vanused 18–70 · Kõik sood · Uuendatud 13. aug 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
VärbamineFaas 3
Vanused 18–80 · Kõik sood · Uuendatud 30. juuli 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- ja veel 3
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 6. juuli 2026 · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Northwestern University, Chicago
VärbamineFaas 1
Vanused 18–70 · Kõik sood · Uuendatud 30. juuni 2026 · NCT06201416A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Northwestern University, Chicago
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. mai 2026 · NCT04422912The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- University of Chicago Medical Center, Chicago
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. märts 2026 · NCT01280825Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.